Piper Sandler on LB Pharmaceuticals Inc (LBRX): 'Competitor Data Highlight LB-102's Blockbuster Value'
Tweet Send to a Friend
Piper Sandler analyst Yasmeen Rahimi reiterated an Overweight rating and $78.00 price target on LB Pharmaceuticals Inc (NASDAQ: LBRX).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
